Fig. 2 (Abstract P017)
From: Abstracts from the 17th European Headache Congress (EHC)

Proportion of patients reaching ≥50% reduction in MMD from baseline by migraine type at months 1, 3, 6, 9, and 12
From: Abstracts from the 17th European Headache Congress (EHC)
Proportion of patients reaching ≥50% reduction in MMD from baseline by migraine type at months 1, 3, 6, 9, and 12